Intracellular membrane trafficking in bone resorbing osteoclasts

被引:74
作者
Mulari, M [1 ]
Vääräniemi, J [1 ]
Väänänen, HK [1 ]
机构
[1] Turku Univ, Inst Biomed, Dept Anat, Turku 20520, Finland
关键词
bone; endocytosis; transcytosis; secretion; Rab7;
D O I
10.1002/jemt.10371
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
There is ample evidence now that the two major events in bone resorption, namely dissolution of hydroxyapatite and degradation of the organic matrix, are performed by osteoclasts. The resorption cycle involves several specific cellular activities, where intracellular vesicular trafficking plays a crucial role. Although details of these processes started to open up only recently, it is clear that vesicular trafficking is needed in several specific steps of osteoclast functioning. Several plasma membrane domains are formed during the polarization of the resorbing cells. Multinucleated osteoclasts create a tight sealing to the extracellular matrix as a first indicator of their resorption activity. Initial steps of the sealing zone formation are alpha(v)beta(3)-integrin mediated, but the final molecular interaction(s) between the plasma membrane and mineralized bone matrix is still unknown. A large number of acidic intracellular vesicles then fuse with the bone-facing plasma membrane to form a ruffled border membrane, which is the actual resorbing organelle. The formation of a ruffled border is regulated by a small GTP-binding protein, rab7, which indicates the late endosomal character of the ruffled border membrane. Details of specific membrane transport processes in the osteoclasts, e.g., the formation of the sealing zone and transcytosis of bone degradation products from the resorption lacuna to the functional secretory domain remain to be clarified. It is tempting to speculate that specific features of vesicular trafficking may offer several potential new targets for drug therapy of bone diseases. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:496 / 503
页数:8
相关论文
共 84 条
[1]   Expression and regulation of RAB3 proteins in osteoclasts and their precursors [J].
Abu-Amer, Y ;
Teitelbaum, SL ;
Chappel, JC ;
Schlesinger, P ;
Ross, FP .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (11) :1855-1860
[2]   Substrate recognition by osteoclast precursors induces c-src/microtubule association [J].
AbuAmer, Y ;
Ross, FP ;
Schlesinger, P ;
Tondravi, MM ;
Teitelbaum, SL .
JOURNAL OF CELL BIOLOGY, 1997, 137 (01) :247-258
[3]   Alendronate disturbs vesicular trafficking in osteoclasts [J].
Alakangas, A ;
Selander, K ;
Mulari, M ;
Halleen, J ;
Lehenkari, P ;
Mönkkönen, J ;
Salo, J ;
Väänänen, K .
CALCIFIED TISSUE INTERNATIONAL, 2002, 70 (01) :40-47
[4]   The related adhesion focal tyrosine kinase differentially phosphorylates p130(Cas) and the Cas-like protein, p105(HEF1) [J].
Astier, A ;
Manie, SN ;
Avraham, H ;
Hirai, H ;
Law, SF ;
Zhang, YH ;
Golemis, EA ;
Fu, YG ;
Druker, BJ ;
Haghayeghi, N ;
Freedman, AS ;
Avraham, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) :19719-19724
[5]   IDENTIFICATION AND CHARACTERIZATION OF A NOVEL RELATED ADHESION FOCAL TYROSINE KINASE (RAFTK) FROM MEGAKARYOCYTES AND BRAIN [J].
AVRAHAM, S ;
LONDON, R ;
FU, YG ;
OTA, S ;
HIREGOWDARA, D ;
LI, JZ ;
JIANG, SX ;
PASZTOR, LN ;
WHITE, RA ;
GROOPMAN, JE ;
AVRAHAM, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27742-27751
[6]   POLARIZED SECRETION OF LYSOSOMAL-ENZYMES - CO-DISTRIBUTION OF CATION-INDEPENDENT MANNOSE-6-PHOSPHATE RECEPTORS AND LYSOSOMAL-ENZYMES ALONG THE OSTEOCLAST EXOCYTIC PATHWAY [J].
BARON, R ;
NEFF, L ;
BROWN, W ;
COURTOY, PJ ;
LOUVARD, D ;
FARQUHAR, MG .
JOURNAL OF CELL BIOLOGY, 1988, 106 (06) :1863-1872
[7]   EVIDENCE FOR A HIGH AND SPECIFIC CONCENTRATION OF (NA+,K+)ATPASE IN THE PLASMA-MEMBRANE OF THE OSTEOCLAST [J].
BARON, R ;
NEFF, L ;
ROY, C ;
BOISVERT, A ;
CAPLAN, M .
CELL, 1986, 46 (02) :311-320
[8]   Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates:: Biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs [J].
Benford, HL ;
Frith, JC ;
Auriola, S ;
Mönkkönen, J ;
Rogers, MJ .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :131-140
[9]   Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase [J].
Bergstrom, JD ;
Bostedor, RG ;
Masarachia, PJ ;
Reszka, AA ;
Rodan, G .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 373 (01) :231-241
[10]   OSTEOCLASTIC BONE-RESORPTION BY A POLARIZED VACUOLAR PROTON PUMP [J].
BLAIR, HC ;
TEITELBAUM, SL ;
GHISELLI, R ;
GLUCK, S .
SCIENCE, 1989, 245 (4920) :855-857